Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
Drug Regulatory Affairs is a study of all aspects within the pharmaceutical development process and how they are subject to various degrees of regulation.
Clinical trials (CTs) are conducted to discover new methods o f interventions that are better than the existing ones. They are conducted as per the guidelines suggested by the drug regulatory authority of the country where they are being conducted In India; CTs are regulated by Central Drugs Standard Control Organisation (CDSCO) in consultation with Indian Council of Medical Research (ICMR) as per the schedule Y of the Drug and Cosmetics Rules, 1945 and Ethical Guidelines for Biomedical Research on Human subjects.
Keywords:
Clinical trials,Regulatory affairs,Irb,Iec
Cite Article:
"REVIEW ON `DRUG REGULATORY AFFAIRS IN CLINICAL TRIALS`", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 9, page no.465 - 467, September-2022, Available :http://www.ijrti.org/papers/IJRTI2209060.pdf
Downloads:
000205517
ISSN:
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator